Senegal’s $7.1m sickle cell drug push targets six African markets
Senegal is stepping up efforts to reduce Africa’s dependence on imported medicines with a $7.1 million pharmaceutical project producing a locally manufactured generic treatment for sickle cell disease and targeting six African markets as production expands …